Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cross-priming in health and disease.

Literature DB >> 20498667

Cross-priming in health and disease.

Christian Kurts¹, Bruce W S Robinson, Percy A Knolle.

Abstract

Cross-priming is an important mechanism to activate cytotoxic T lymphocytes (CTLs) for immune defence against viruses and tumours. Although it was discovered more than 25 years ago, we have only recently gained insight into the underlying cellular and molecular mechanisms, and we are just beginning to understand its physiological importance in health and disease. Here we summarize current concepts on the cross-talk between the immune cells involved in CTL cross-priming and on its role in antimicrobial and antitumour defence, as well as in immune-mediated diseases.

Entities: Disease

Mesh：

Year: 2010 PMID： 20498667 DOI： 10.1038/nri2780

Source DB: PubMed Journal: Nat Rev Immunol ISSN： 1474-1733 Impact factor: 53.106

163 in total

1. Phagosomes are competent organelles for antigen cross-presentation.

Authors: Mathieu Houde; Sylvie Bertholet; Etienne Gagnon; Sylvain Brunet; Guillaume Goyette; Annie Laplante; Michael F Princiotta; Pierre Thibault; David Sacks; Michel Desjardins
Journal: Nature Date: 2003-09-25 Impact factor: 49.962

Review 2. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.

Authors: Martin J Richer; Marc S Horwitz
Journal: Autoimmun Rev Date: 2009-02-11 Impact factor: 9.754

3. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

Authors: Tiziana Di Pucchio; Bithi Chatterjee; Anna Smed-Sörensen; Sandra Clayton; Adam Palazzo; Monica Montes; Yaming Xue; Ira Mellman; Jacques Banchereau; John E Connolly
Journal: Nat Immunol Date: 2008-03-30 Impact factor: 25.606

Review 4. Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?

Authors: Cornelis J M Melief
Journal: Eur J Immunol Date: 2003-10 Impact factor: 5.532

5. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.

Authors: Anna K Nowak; Richard A Lake; Amanda L Marzo; Bernadette Scott; William R Heath; Edward J Collins; Jeffrey A Frelinger; Bruce W S Robinson
Journal: J Immunol Date: 2003-05-15 Impact factor: 5.422

Review 6. Tumor antigens recognized by T lymphocytes.

Authors: T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal: Annu Rev Immunol Date: 1994 Impact factor: 28.527

7. Efficient cross-presentation depends on autophagy in tumor cells.

Authors: Yuhuan Li; Li-Xin Wang; Guojun Yang; Fang Hao; Walter J Urba; Hong-Ming Hu
Journal: Cancer Res Date: 2008-09-01 Impact factor: 12.701

8. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors: M J Bevan
Journal: J Exp Med Date: 1976-05-01 Impact factor: 14.307

9. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.

Authors: Eric F Tewalt; Jean M Grant; Erica L Granger; Douglas C Palmer; Neal D Heuss; Dale S Gregerson; Nicholas P Restifo; Christopher C Norbury
Journal: PLoS Pathog Date: 2009-05-29 Impact factor: 6.823

10. B cells directly tolerize CD8(+) T cells.

Authors: S R Bennett; F R Carbone; T Toy; J F Miller; W R Heath
Journal: J Exp Med Date: 1998-12-07 Impact factor: 14.307

165 in total

Review 1. Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors: Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal: Nat Rev Immunol Date: 2011-11-11 Impact factor: 53.106

Review 2. Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors: Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal: Expert Rev Vaccines Date: 2011-11 Impact factor: 5.217

3. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination.

Authors: Chiara Nembrini; Armando Stano; Karen Y Dane; Marie Ballester; André J van der Vlies; Benjamin J Marsland; Melody A Swartz; Jeffrey A Hubbell
Journal: Proc Natl Acad Sci U S A Date: 2011-10-03 Impact factor: 11.205

Review 4. Properties and applications of single-chain major histocompatibility complex class I molecules.

Authors: Eleni Kotsiou; Joanna Brzostek; Keith G Gould
Journal: Antioxid Redox Signal Date: 2011-03-31 Impact factor: 8.401

Review 5. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors: Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal: Nat Rev Immunol Date: 2010-11-19 Impact factor: 53.106

6. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors: Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal: Proc Natl Acad Sci U S A Date: 2012-07-09 Impact factor: 11.205